Your browser doesn't support javascript.
loading
International Peanut Allergy Prevention, 6 Years After the Learning Early About Peanut Study.
Abrams, Elissa M; Shaker, Marcus; Greenhawt, Matthew; Mack, Douglas P.
Afiliação
  • Abrams EM; Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Shaker M; Section of Allergy and Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Geisel School of Medicine, Dartmouth, Hanover, NH.
  • Greenhawt M; Section of Allergy/Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo. Electronic address: Matthew.Greenhawt@childrenscolorado.org.
  • Mack DP; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada; Halton Pediatric Allergy, Burlington, Ontario, Canada.
J Allergy Clin Immunol Pract ; 10(1): 71-77, 2022 01.
Article em En | MEDLINE | ID: mdl-34311123
ABSTRACT
Six years ago, the Learning Early About Peanut (LEAP) trial findings helped fundamentally shift the paradigm of peanut allergy prevention. Although the results of LEAP are well accepted, policy-makers, caregivers, and clinicians struggle with how best to implement and apply the study's key findings in clinical practice. Differences in guidelines highlight issues related to peanut allergy prevention implementation, including caregiver acceptability, cost, fidelity, feasibility, appropriateness, and adoption. The goals of this rostrum are to review how the LEAP study has informed international peanut allergy prevention policy, as well as to review the strengths and ongoing controversies in peanut allergy prevention implementation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipersensibilidade a Amendoim Tipo de estudo: Guideline / Prognostic_studies Limite: Humans / Infant Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipersensibilidade a Amendoim Tipo de estudo: Guideline / Prognostic_studies Limite: Humans / Infant Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá